comparemela.com

Latest Breaking News On - Michel vounatsos - Page 1 : comparemela.com

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO

Neurocrine, a regular name on Wall Street s M&A lists, elevates BD chief to succeed founder and CEO
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

The Escalator: VML Health, Madrigal Pharmaceuticals, CG Life and more

Biogen Says Goodbye to Beleaguered Alzheimer s Drug Aduhelm

Biogen has returned its Aduhelm rights to Neurimmune, the company that initially developed the antibody Alzheimer’s disease drug. But Biogen isn’t abandoning Alzheimer’s, and its pipeline includes drugs that take other approaches to the neurodegenerative disorder.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.